Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Whether Using DNA Methylome to Select Embryos Can Increase the Live Birth Rate During Assisted Reproductive Technology: A Multicenter, Randomized , Open-label Clinical Trial.

NCT05442125 is registered in ClinicalTrials.gov with Shandong University as lead sponsor.

NCT NCT05442125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05442125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Whether Using DNA Methylome to Select Embryos Can Increase the Live Birth Rate During Assisted Reproductive Technology: A Multicenter, Randomized , Open-label Clinical Trial.
Lead sponsor
Shandong University
Phase
Not applicable
Overall status
Unknown status
Start date
September 16, 2022
Completion date
May 31, 2025
Enrollment
1,146 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

dna methylation, reproductive techniques, assisted